Biography

Todd Schwedt, MD, MSCI is a Professor of Neurology and Chair of Neurology Research at the Mayo Clinic Arizona.  In addition to his clinical duties in the Mayo Headache Clinic, he leads an active headache research portfolio.  He is a principal investigator of the Neuroimaging of Headache Laboratory at Mayo Clinic, of the American Registry for Migraine Research (ARMR), the Medication Overuse Treatment Strategy Trial (MOTS), and he is the Medical Director of the Mayo Clinic Arizona Clinical Studies Unit. He was a recipient of the 2015 Harold G. Wolff Award from the American Headache Society, an award presented annually to a researcher who has most significantly contributed to the understanding of headache. Dr. Schwedt serves on the Executive Committee for the Board of Directors for the American Headache Society, is Co-Chair for the 2021 International Headache Congress, is a member of the American Headache Society scientific meeting planning committee, is the chairperson of the post-traumatic headache working group for the International Classification of Headache Disorders, and is an associate editor for Cephalalgia, Headache, and Headache Currents. Dr. Schwedt is a frequent lecturer and has authored over 115 peer-reviewed publications.

Disclosures

 

Society Leadership/Board position: American Headache Society, American Migraine Foundation Personal fees: Alder, Allergan, Amgen, Biohaven, Cipla, Click Therapeutics, Eli Lilly, Equinox, Ipsen, Lundbeck, Novartis, Promius, Teva, Tonix, XoC, Weber and Weber Research support: Amgen, National Institutes of Health, US Department of Defense, Patient Centered Outcomes Research Institute, Henry Jackson Foundation, American Migraine Foundation (all to institution) Royalties/licences: UpToDate Patents: US Patent application 17/292,339 Relationship with scientific journals: Cephalalgia, Cephalalgia Reports Commercial interests: Aural Analytics; Nocira, Second Opinion